Insider Transactions in Q2 2025 at Avidity Biosciences, Inc. (RNA)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 11
2025
|
W. Michael Flanagan Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
20,000
-19.96%
|
$640,000
$32.88 P/Share
|
|
Jun 11
2025
|
W. Michael Flanagan Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+16.64%
|
$280,000
$14.22 P/Share
|
|
Jun 10
2025
|
Carsten Boess Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,692
+50.0%
|
-
|
|
Jun 10
2025
|
Noreen Henig Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,692
+50.0%
|
-
|
|
Jun 10
2025
|
Arthur A Levin Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,692
+25.4%
|
-
|
|
Jun 10
2025
|
Edward M. Md Kaye Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,692
+50.0%
|
-
|
|
Jun 10
2025
|
Simona Skerjanec Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,692
+50.0%
|
-
|
|
Jun 10
2025
|
Troy Edward Wilson Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,692
+8.79%
|
-
|
|
Jun 10
2025
|
Jean Jinsun Kim Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,692
+50.0%
|
-
|
|
Jun 10
2025
|
Tamar Thompson Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,692
+50.0%
|
-
|
|
Jun 02
2025
|
Kathleen P. Gallagher Chief Program Officer |
SELL
Open market or private sale
|
Direct |
5,875
-10.41%
|
$188,000
$32.48 P/Share
|
|
Jun 02
2025
|
Kathleen P. Gallagher Chief Program Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,875
+9.43%
|
$94,000
$16.65 P/Share
|
|
May 01
2025
|
Kathleen P. Gallagher Chief Program Officer |
SELL
Open market or private sale
|
Direct |
5,875
-10.41%
|
$188,000
$32.4 P/Share
|
|
May 01
2025
|
Kathleen P. Gallagher Chief Program Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,875
+9.43%
|
$94,000
$16.65 P/Share
|
|
Apr 01
2025
|
Kathleen P. Gallagher Chief Program Officer |
SELL
Open market or private sale
|
Direct |
5,875
-5.27%
|
$158,625
$27.83 P/Share
|
|
Apr 01
2025
|
Kathleen P. Gallagher Chief Program Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,875
+4.82%
|
$88,125
$15.68 P/Share
|